ABSTRACT: Atmospheric plasma is attracting interest for medical applications and clinical phases. We adduce the following questions to guide the future research in plasma medicine.
I. INTRODUCTION
Medical applications of atmospheric plasma have been intensively studied. 1 These studies have reported numerous applications, such as for sterilization, 2,3 decomposition of harmful substances, 4 and surface treatments. [5] [6] [7] In recent year, this area of research has been focused on the practical utilization of atmospheric plasma in the medical field, such as for blood coagulation, 8, 9 wound healing, [10] [11] [12] and cancer treatment. [13] [14] [15] On the other hand, dermatology is one area of the medical field where atmospheric plasma applications are currently used in practice, 16 such as in a device to treat acne or wrinkles 17 and to treat stretch marks in combination with ultrasonic waves. 18, 19 As explained previously above, various research and development efforts have been conducted in the application of plasma medicine; however, we do not yet know whether plasma irradiation can be used to treat various symptoms. A special issue of this journal introduces the basic mechanisms of cell response and the bacterial sterilization process, as well as the clinical case applications. However, questions remain regarding the effectiveness of plasma medicine in treating depression, which is a social problem in contemporary countries such as Japan, and Alzheimer's disease, which is an increasing problem in aging societies. Use of plasma medicine to treat various other diseases, such as cerebral infarction and high blood pressure, also requires additional investigation. Reactive oxygen species (ROSs) and reactive nitrogen species (RNSs) could play an important role in the beneficial effects of plasma medicine. Mechanisms underlying these effects could be quite complicated because of the physiological activation in the body by ROS signaling. 20 Fundamental research to elucidate the cellular response is currently under investigation. In contrast, reactive species generated in plasma or exposed liquid medium have demonstrated efficacy for treating various cancers, but not for the previously mentioned mental disorders, other associated symptoms, or diseases such as diabetes, cerebral infarction, and high blood pressure. 21 Fortunately, mechanisms of depression and Alzheimer's disease have been revealed in detail. The inhibited production of neurotransmitters (serotonin, noradrenalin, and dopamine) causes depression, and Alzheimer's disease occurs because of the deposition of a peptide called amyloid-ß on the cerebral cortex. Research and development of effective drugs for treating mental disorders are proceeding at a certain rate. 22 These drugs are administrated orally; however, the effects of many of these drugs are delayed because of absorption in the small intestine. Moreover, as is the case with oral administration, absorption of drugs in additional locations is different for each person. Thus, administration by injection is used if a precise or high dose of drugs is needed. 23, 24 Administration of poorly absorbed drugs is also the same. However, highly frequent injections are not desirable in the view of a patient's quality of life (QOL). We can adduce the following questions to guide the future of plasma medicine and develop it into a strong tool for the treatment of various symptoms.
1. Is plasma medicine an effective method for treating various symptoms? 2.
If not, what combination of drugs in addition to plasma irradiation will be required?
3. Can plasma irradiation be an effective method for drug administration? As mentioned in many of the references, recent studies of plasma medicine are mostly focused on direct or indirect actions of the active species. Hence, clinical cases, such as Alzheimer's disease, diabetes, cerebral infarction, and high blood pressure, have not yet been investigated to determine whether reactive species and plasma medicine could be an effective treatment. Applying plasma medicine for treatment of various symptoms, we have been considering plasma irradiation as a method to deliver appropriate drugs. 25 One instance of this use is the enhancement of percutaneous absorption by atmospheric microplasma irradiation. Percutaneous absorption is a drug administration method in which drugs are absorbed into the skin or body. In this sense, this method is similar to an injection; however, there is no need for a needle in plasma irradiation. Administering drugs in ways that do not require needles could increase patient QOL and reduce the rate of infections. In addition, percutaneous absorption has several ad-vantages, such as preventing metabolism of the drug 24 and stabilizing the concentration of drug in the blood. 26 However, it has disadvantages as well, such as the limitation of the molecular weight of the drug 27 and the need for moderate solubility of the drug in lipids. 28 The stratum corneum (SC) layer inhibits drug penetration because the skin acts as a barrier to guard our body from foreign substances.
In this article, we review and present a feasibility study of the enhancement of percutaneous absorption with microplasma irradiation. In this method, reagents were placed on the skin after a microplasma irradiation generated by applying 0.6 kV high frequency AC (27 kHz).
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II. EXPERIMENTAL SETUP
A. Preparation of Skin Sample
Yucatan Micropig skin (female, 5 months; Charles River, Yokohama, Japan), removed from the back, was used as the skin sample. The fat layer was removed from the pig skin using scissors and sand paper. It was then immersed in phosphate buffered saline (PBS) for 3 hours. The skin was then immersed for 1 min in PBS at 60°C, and finally, the SC layer was peeled off with tweezers and used as a biological sample. The thickness of the SC sample was about 500 mm. Figure 1 shows the experimental setup for the atmospheric microplasma irradiation procedure. 25, 29 Discharge voltage was measured using a high-voltage probe (P6105A, Tektronix, Beaverton, OR, USA) and an oscilloscope (TDS 2014, Tektronix). Discharge
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B. Procedure for Atmospheric Microplasma Irradiation
FIG. 1:
The experimental setup for microplasma irradiation.
current was measured using a current probe (P6021, Tektronix) and an oscilloscope.
A film electrode was used to generate the microplasma. The film electrode has two conductive parts, with a dielectric layer sandwiched between them. 25 The atmospheric microplasma was generated on the gap formed by the conductive and dielectric layers of film electrode when a high AC voltage (V 0-p = 0.6 kV, 27 kHz) was applied with flowing argon (Ar) gas (5 L/min). Pig skin samples were placed on the Z stage to control the distance between the film electrode and skin sample in an open space. Typically, the distance between the film electrode and skin sample was set at 50 mm with a thickness gauge and Z stage. Exposure times were set to 1 and 5 min.
Atmospheric plasma jet discharge was also used to compare transdermal absorbance of drug with atmospheric microplasma. The plasma jet electrode consists of a glass tube (outer diameter 5.0 mm, inner diameter 2.6 mm) and tungsten wire (0.8 mm diameter). A sinusoidal high voltage (V 0-p = 5 kV, 16 kHz) was applied to the tungsten wire with flowing argon gas. The distance between the tip of the plasma jet electrode and the sample surface was set at 5 mm. Exposure times were set to 10 and 30 sec for both microscopic observations, and for transdermal absorption of drugs, respectively.
The surface of the film electrode was connected to the ground and a high voltage was applied to the back side of the film. Thus, there was no risk of electric shock to users, even when touching the surface of the film electrode.
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C. In Vivo Transdermal Absorption
The pig skin sample was placed on a Franz-type diffusion cell (TP-8S, Biocom Systems, Fukuoka, Japan) with an effective area of 1.8 cm 2 as shown in Fig. 2 . Phenol red solution was used to estimate the effect of atmospheric microplasma irradiation on transdermal drug delivery. 1 mL of phenol red (1.2 mg/mL) was applied to the donor part of the diffusion cell, and the receptor was filled with 7 mL of PBS.
FIG. 2:
The experimental set up for transdermal absorption of phenol red with pig skin sample.
An amount of 5 mL of the PBS in the receptor was sampled and replaced and the phenol red concentration estimated by a spectrophotometer (V-670, JASCO, Tokyo, Japan) at a wavelength of 558 nm. The temperature of the receptor cell was maintained at 32°C with a water bath.
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D. Tape Stripping Test
The tape stripping test is a representative method for estimating the barrier performance of skin and other properties of the SC. 31 In this study, a tape stripping test was used to evaluate the effect of atmospheric microplasma irradiation on pig skin barrier performance. Scotch tape (Sumitomo, 3M) was stuck to the surface of a pig skin sample and peeled off. The tape stripping was conducted 10 and 20 times, and then the pig skin samples were analyzed by attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy (FT/IR 6300 series, JASCO) to compare them with samples subjected to atmospheric microplasma irradiation.
E. ATR-FTIR Spectroscopy
There is a wide variety of methods available for analyzing skin structure and other properties, such as Raman spectroscopy, 32 X-ray diffraction, 33 electron diffraction, 34 and transmission electron microscopy. 35 ATR-FTIR is also a useful method for analyzing skin, 36 so it was used to analyze exposed pig skin samples. Resolution and cumulated number were set at 1.0 cm -1 and 64 times, respectively. Several peaks associated with chemical functional groups were found. The measuring wave number was set between 2800 cm -1 and 3100 cm -1 , which indicate CH 2 symmetric and asymmetric stretching modes, respectively. 37 The absorbance of the spectrum decreases as the thickness of the skin decreases 37 and the measuring wave number range indicates a change in chain conformation, especially a change in peak shape.
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F. Transepidermal Water Loss Measurement
Barrier properties of the SC can be confirmed by the transepidermal water loss (TEWL) test, which indicates water evaporation from the inner body through skin. 39 In this study, pig skin samples treated by atmospheric microplasma irradiation, atmospheric plasma jet, and tape stripping test were evaluated by this method. Pig skin samples (Yucatan Micropig, 6 months, female; Charles River) were exposed to microplasma for 5 minutes, and 30 seconds for atmospheric plasma jet irradiation. The TEWL was then measured with an evaporimeter (H4500, Nikkiso Thermo, Japan) for comparison with the control samples.
G. Histological Sectioning
The subcutaneous fat-removed pig skins were treated by microplasma, plasma jet or Shimizu tape stripping. A small surface (approximately 3 × 15 mm 2 ) of the treated skin was cut and fixed in 10% neutral buffered formalin for 4 days. This formalin solution contains stock of formaldehyde solution (35% CH 2 O, 1 L), sodium phosphate monobasic (NaH 2 PO 4 •H 2 O : 44 g), sodium phosphate dibasic anhydrous (Na 2 HPO 4 , 65 g) and distilled water (9 L). Afterward, the skin was dehydrated and embedded into paraffin mold. The paraffin-embedded skin sample was sectioned at a thickness of several μm using a microtome and placed on a glass side. In order to visualize the micro-scale change in the stratum corneum, hematoxylin-eosin staining was then performed. Figure 3 shows quantitative measurements of phenol red absorption after both atmospheric microplasma and plasma jet irradiation (Fig. 3(b) ). After 5 min microplasma irradiation, absorption was enhanced threefold relative to control samples ( Fig. 3(a) ). Penetration characteristics were similar to those of iontophoretically treated skin. 40 This result suggests that transdermal drug penetration can be enhanced by atmospheric plasma irradiation.
III. RESULTS AND DISCUSSION
A. Phenol Red Absorption of Pig Skin
For the case of the atmospheric plasma jet, dye penetration was 40 times higher than that of microplasma irradiation. The cumulative value was saturated, meaning that the phenol red dye penetrated through the SC layer, because the SC was damaged and numerous pores with diameters ranging from 40 to 100 µm were generated by plasma jet irradiation. This penetration characteristic was similar to those when microneedle and iontophoresis treatments were applied. 41 In the next section, we discuss the physical damage caused by plasma jet irradiation in comparison with that caused by microplasma irradiation. We also discuss the effect of tape stripping, which enhances transdermal drug delivery more than that by microplasma irradiation because it removes the SC. Figure 4 shows the CH 2 spectra of a pig skin sample exposed to atmospheric microplasma. The absorbance of the skin sample decreased as the exposure time to atmospheric microplasma increased. This result could have occurred because the SC layer was physically and chemically changed by the atmospheric microplasma irradiation, suggesting that the atmospheric microplasma has the potential to enhance drug penetration through the skin because the SC layer acts as a barrier. Figure 5 shows the CH 2 spectra of a pig skin sample exposed to atmospheric plasma jet. The absorbance of the skin sample decreased only with exposure times of 10 or 20 seconds, compared to the control samples. This result could have occurred because the SC layer was damaged by the atmospheric plasma jet irradiation with the electric field or an etching effect from bombardment with charged particles such as ions. Figure 6 shows the CH 2 spectra of the pig skin sample before and after the tape stripping test. Absorbance of the CH 2 peaks decreased as the number of tape stripping cycles was increased. This result shows that the barrier performance of the SC was impaired by tape stripping, because the SC layer was removed by applying and peeling off the scotch tape. Figure 7 shows the TEWL measurements of the control sample, microplasma irradiation sample, tape stripping test sample, and plasma jet irradiation sample, where each measurement was repeated four times. The TEWL of the atmospheric microplasma irradiation samples (exposure time 5 min) increased relative to the control samples (subjected only to Ar gas flow). After microplasma irradiation of the pig skin sample, TEWL increased to almost double its original value, suggesting that the barrier properties were decreased through atmospheric microplasma irradiation. In comparison, the TEWL of the tape stripping sample skin increased more than three times compared with the con- This result suggests that the barrier properties were decreased by irradiating with atmospheric microplasma as well as by the tape stripping test. The effect of microplasma irradiation was relatively weak, similar to the result of the ATR-FTIR analysis (Fig. 4) , compared with that of the tape stripping test. In the next section, we further discuss the relationship between the barrier function of skin samples and the physical damage to skin samples, focusing on plasma jet irradiation.
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B. Effect of Microplasma Irradiation on CH 2 Spectra
C. Effect of Atmospheric Plasma Jet Irradiation on CH 2 Spectra
D. Tape Stripping Test CH 2 Spectra
E. TEWL Measurement for Estimating the Barrier Function of Skin
F. Physical Damage to Skin and the Effect of a Strong Applied Electric Field
Physical damage to the skin could be minimized with care during atmospheric plasma irradiation. Observation of the pig skin surface was carried out using an optical microscope (Leica DM IL LED, Leica Microsystems, Wetzlar, Germany). Little difference in physical damage was observed between the control pig skin sample and after microplasma irradiation as shown in Fig. 8 .
After 10 sec of atmospheric plasma jet irradiation, small pores (ranging from 40 to 100 µm) were observed as shown in Fig. 9 . In addition to the pores, formation of holes was also confirmed after longer operation (3 min) of atmospheric plasma irradiation. 25 These physical damages to the skin could be caused by the electric field or an etching effect from bombardment with charged particles, but not by UV radiation nor thermal damage. 43 This physical damage could affect the barrier function of skin samples. For the tape stripping test, surface asperity was decreased, as shown in Fig. 10 . Application of a strong electric field resulted not only in pore formation on the skin but also removal of the SC was observed, as shown in Fig. 11 . The SC layer (the white part, thickness was about 18.1 μm in Fig. 11(a) control sample) was physically removed after 20 tape stripping cycles and its thickness was about 6.0 μm, as shown in Fig.  11(b) . After 30 seconds of atmospheric plasma jet irradiation, most of the SC layer was removed and its thickness was about 3.5 μm, as shown in Fig. 11(c) . In the microplasma case, the SC layer was slightly removed, even after 5 min irradiation, and its thickness was about 13.4 μm as shown in Fig. 11(d) .
Transdermal dye delivery was confirmed by high-voltage dielectric barrier discharge (20 kV), 44 and we also confirmed that transdermal drug delivery could be enhanced more after atmospheric plasma jet irradiation than after microplasma irradiation, because the barrier function of the skin could be lost through pores formation or removal of the SC layer. Dynamic behavior of the intercellular lipids between the SC layer could be considered to enhance transdermal dye delivery without SC layer removal or pore formation by microplasma irradiation. 25 Kalghatgi et al. 44 suggested that atmospheric plasma enhances transdermal drug delivery by temporary pore formation in the skin. Further investigation is necessary to improve transdermal drug delivery without physical damage to the skin surface, and to elucidate the mechanisms of plasma drug delivery.
IV. CONCLUSION
Pig skin samples were irradiated with atmospheric microplasma to investigate the feasibility of enhancing drug penetration through the SC. The following results were obtained through this series of experiments:
1. With the atmospheric microplasma irradiation, phenol red absorption was enhanced through pig skin compared with the control sample. Atmospheric plasma jet irradiation caused much higher dye penetration through the pig skin samples than microplasma irradiation, and also caused pore or hole formation. Penetration of dye or drugs by plasma jet irradiation could be considered as a trade off relationship. It is accompanied by physical damage or pain on the skin, similar to that from an ordinary hypodermic needle.
2. In surface analysis by ATR-FTIR, the absorbance of the CH 2 peak decreased as exposure time increased. Comparison with the tape stripping test showed that the SC layer could be altered by atmospheric microplasma irradiation, suggesting enhanced drug penetration through the skin.
3. TEWL measurements showed that the barrier properties of the pig skin sample were decreased by atmospheric microplasma irradiation.
4. Physical damage, such as pore formation or SC layer removal, was observed after atmospheric plasma jet irradiation, accompanied with a high electric field and etching effect. After microplasma irradiation, physical damage such as pore or hole formation or removal of the SC layer was hardly observed. This could be caused by the low driven voltage, and relatively weak electric field compared with plasma jet irradiation. Dy- We suggest that use of a percutaneous absorption promoter with plasma irradiation is feasible, and thus, could be combined with appropriate drugs to target various symptoms such as Alzheimer's disease, diabetes, and other symptoms that cannot be cured by applying plasma irradiation alone. This novel method will reveal new directions for the future of plasma medicine. We aim to combine a safe transdermal drug delivery method with a transdermal agent such as a peptide vaccine without requiring an injection needle or causing physical damage to the skin. Special care to prevent or minimize physical damage to the skin should also be considered through use of plasma irradiation.
Further investigation is necessary to improve atmospheric microplasma irradiation for future clinical trials. Safety of patients, without causing harmful damage or physical damage to the skin, is critical to enabling this novel technology. 
